Literature DB >> 28390534

PET/MR Imaging of Multiple Myeloma.

Shetal N Shah1, Jorge D Oldan2.   

Abstract

PET-magnetic resonance (MR) is a hybrid imaging modality that combines PET and MR. Evidence for this new modality is in the process of being developed, but both component modalities are well tested in the diagnosis and management of multiple myeloma. It allows advanced bimodality imaging of the whole body with an adaptable field of view and it can be used for monitoring plasma cell dyscrasias for progression to multiple myeloma, for assessing disease burden in patients with known multiple myeloma, for assessing response to therapy and relapse after remission, and for radiation therapy treatment planning.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MRI; Multiple myeloma; PET; Plasma cell dyscrasias

Mesh:

Year:  2017        PMID: 28390534     DOI: 10.1016/j.mric.2017.01.003

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  4 in total

Review 1.  Advanced Imaging of Multiple Myeloma Bone Disease.

Authors:  Barry G Hansford; Rebecca Silbermann
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-07       Impact factor: 5.555

2.  MiR-657/ATF2 Signaling Pathway Has a Critical Role in Spatholobus suberectus Dunn Extract-Induced Apoptosis in U266 and U937 Cells.

Authors:  Hyun Ji Lim; Moon Nyeo Park; Changmin Kim; Beomku Kang; Hyo-Sook Song; Hyemin Lee; Sung-Hoon Kim; Bum-Sang Shim; Bonglee Kim
Journal:  Cancers (Basel)       Date:  2019-01-28       Impact factor: 6.639

3.  Agreement Between 18F-FDG PET/CT and Whole-Body Magnetic Resonance Compared With Skeletal Survey for Initial Staging and Response at End-of-Treatment Evaluation of Patients With Multiple Myeloma.

Authors:  Nieves Gómez León; Beatriz Aguado Bueno; María Herreros Pérez; Luisa F León Ramírez; Adrián Alegre; Patrick M Colletti; Domenico Rubello; José L Carreras; Roberto C Delgado Bolton
Journal:  Clin Nucl Med       Date:  2021-04-01       Impact factor: 10.782

4.  PET/CT F18-FDG with soft tissue plasmacytomas in multiple myeloma.

Authors:  Alejandro Martí; Sarai Morón; Sandra Chinchilla; Eliana González
Journal:  Eur J Hybrid Imaging       Date:  2021-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.